Fig. 10
From: Prognostic and therapeutic relevance of IL2RG-related LncRNAs in clear cell renal cell carcinoma
Drug sensitivity analysis. Differences in drug sensitivity between high-risk and low-risk groups for Sunitinib (A), Sorafenib (B), Temsirolimus (C), Axitinib (D), and Pazopanib (E).
